Home > Authorities > Institutes > Record #133008 |
AG Jucker
Cell Biology of Neurological Diseases Also known as:AG Jucker; Cell Biology of Neurologic Diseases; Zellbiologie Neurologischer Erkrankungen; Zellbiologie neurologischer ErkrankungenID | I:(DE-2719)1210001 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.
Alzheimer's and dementia 21(7), e70347 (2025) [10.1002/alz.70347]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onset.
Brain 148(7), 2429 - 2440 (2025) [10.1093/brain/awaf038]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease.
The journal of prevention of Alzheimer's disease 12(6), 100133 (2025) [10.1016/j.tjpad.2025.100133]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Erratum/Correction)
Erratum: Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's disease.
Network neuroscience 9(1), i (2025) [10.1162/netn_x_00462]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.
Acta neuropathologica 149(1), 57 (2025) [10.1007/s00401-025-02890-7]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Ubiquitin-proteasome system in the different stages of dominantly inherited Alzheimer's disease.
Alzheimer's and dementia 21(5), e70243 (2025) [10.1002/alz.70243]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's disease.
Alzheimer's and dementia 21(4), e70146 (2025) [10.1002/alz.70146]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial.
The lancet 24(4), 316 - 330 (2025) [10.1016/S1474-4422(25)00024-9]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Contribution to a book
Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World Settings.
Biomarkers for Alzheimer’s Disease Drug Development / Perneczky, Robert (Editor) ; New York, NY : Springer US, 2024, Chapter 1 ; ISSN: 1064-3745=1940-6029 ; ISBN: 978-1-0716-3773-9=978-1-0716-3774-6 ; doi:10.1007/978-1-0716-3774-6
New York, NY : Springer US, Methods in Molecular Biology 2785, 3 - 14 (2024) [10.1007/978-1-0716-3774-6_1]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's disease.
Network neuroscience 8(4), 1265 - 1290 (2024) [10.1162/netn_a_00395]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |